RPL13A is a ribosomal protein with dual roles in canonical and extra-ribosomal functions 1234. As a structural component of the 60S ribosomal subunit, RPL13A participates in rRNA methylation 5. Beyond ribosomal assembly, RPL13A functions as a core component of the GAIT (gamma interferon-activated inhibitor of translation) complex 6. Upon interferon-gamma activation and phosphorylation, RPL13A dissociates from ribosomes and assembles into the GAIT complex, which binds GAIT elements in 3'-UTRs of inflammatory mRNAs (e.g., ceruloplasmin) to suppress their translation by blocking 43S ribosomal complex recruitment 6. Clinically, RPL13A harbors snoRNA genes (U32, U33, U34, U35) in its introns 7 that regulate reactive oxygen species (ROS) levels in erythrocytes. In sickle cell disease, elevated Rpl13a snoRNA levels increase ROS through peroxiredoxin-2 methylation modifications, contributing to vaso-occlusion; antisense targeting of snoRNAs U34 and U35a reduces ROS and ameliorates disease pathology 8. Similarly, in aging and venous thromboembolism, Rpl13a snoRNAs promote ROS-dependent complement C3a deposition and thrombosis via NADPH oxidase 1 activation 910. RPL13A demonstrates remarkable transcriptional stability across diverse treatments and cell types, making it a reliable housekeeping gene for qRT-PCR normalization 11121314.